Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
Sponsor: Do Hyun Park
Summary
Purpose Pancreatic cancer is the fourth leading cancer-related mortality disease in the United States, with a five-year survival rate of 11%, and only 10 15% of all pancreatic cancer patients are operable or borderline operable. Therefore, there is an unmet need for early diagnosis of pancreatic cancer; however, biomarkers related to this are not well understood. This study aims to identify biomarkers for the early diagnosis of pancreatic cancer through duodenal pancreatic juice, which can be easily obtained through an endoscopy.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
263
Start Date
2024-01-02
Completion Date
2026-12-31
Last Updated
2025-06-22
Healthy Volunteers
Yes
Conditions
Locations (3)
University of Colorado Hospital
Aurora, Colorado, United States
Cleveland Clinic
Cleveland, Ohio, United States
Asan Medical Center
Seoul, South Korea